Renascience

Renascience Profit per Employee

The Profit per Employee of Renascience (4889.T) as of Nov 19, 2026 is -100.43 M JPY. In the previous year, Profit per Employee was 37.81 M JPY — a change of -365.61% (lower).

Profit per Employee

-100.43 MJPY

YoY

-365.61%

Last updated:

Profit per Employee of Renascience is 2026 -100.43 M JPY. Profit per Employee of Renascience was 2025 37.81 M JPY. It decreases by -365.61% lower compared to the previous year.

The Renascience Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2020
-61.33 M JPY
Jan 1, 2021
-33.35 M JPY
Jan 1, 2022
-84.76 M JPY
Jan 1, 2023
-111.93 M JPY
Jan 1, 2024
-86.11 M JPY
Jan 1, 2025
37.81 M JPY
Jan 1, 2026
-100.43 M JPY
The Renascience Profit per Employee history
YEARProfit per EmployeeYoY
-100.43 MJPY-365.61%
37.81 MJPY-143.91%
-86.11 MJPY-23.07%
-111.93 MJPY+32.05%
-84.76 MJPY+154.15%
-33.35 MJPY-45.62%
-61.33 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renascience Stock analysis

What does Renascience do? Renascience, Inc. develops and sells pharmaceuticals, focusing on drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The company collaborates with physicians in research and development of pharmaceuticals, medical devices, and AI solutions for medical problems. Its products target aging-related health issues, including women's and children's diseases and solutions for COVID-19 infection. The firm's revenue comes from the sale of developed pharmaceuticals, medical devices, and AI solutions. Physicians and medical institutions are key buyers of its products, as the company's R&D is conducted in collaboration with them. The primary market segments are aging populations suffering from chronic conditions and healthcare providers seeking innovative medical solutions. Renascience, Inc. operates with a small team of three full-time employees, emphasizing focused R&D on specific medical challenges. Its business model centers on developing targeted therapies for high-impact diseases, leveraging partnerships with physicians to address unmet medical needs in aging-related health conditions. Renascience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renascience stock

Profit per Employee of Renascience is -100.43 M JPY in 2026.

Profit per Employee of Renascience changed from 37.81 M JPY to -100.43 M JPY, representing a -365.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Renascience since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Renascience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Renascience

All Key Metrics — Renascience